FDA initiates pilot program for evaluating AI-designed drugs
Over 200 drugs developed using artificial intelligence are currently in clinical trials around the world. To date, none have received FDA approval.
The Food and Drug Administration has introduced a pilot initiative aimed at determining how to assess AI-generated evidence in drug applications. Ten companies have been selected for an accelerated, interactive review process.
Development in the AI pharmaceutical sector has progressed more rapidly than existing regulatory guidelines. This situation now defines the state of AI-driven drug development.
AI for the masses, craft for the rich. What do you think about this? 👀
Brands like Dior or Prada invest in hand drawn animation, where you can feel the time and the hands behind it. Meanwhile Coca Cola makes its Christmas campaign with AI.
When anyone can generate “perfect” in seconds, the human touch becomes the distinctive thing.
Is AI becoming the look of mass market, while craft becomes the new luxury? 🤔
An exploration of art, creativity, and creative direction through the lens of AI 🌸
This is an independent, experimental concept project, created entirely with AI to explore new possibilities in visual storytelling, artistic expression, and creative direction.
The work incorporates AESOP brand assets and identity, which remain the property of their respective owners. This is a personal creative exploration, not an official AESOP campaign or commissioned work.
Created with AI. Directed by me.
A concept. A creative experiment. A vision brought to life through AI.
One page with brand, web and product UI together is a strong move. Clients see the range without clicking around. Rebuilding mine with AI coding tools taught me the same thing: the speed lets you spend the saved time on the case study writing, which is what actually wins work.